Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson's Disease

Parkinson's disease (PD), a complex neurodegenerative disorder, is pathologically characterized by the formation of Lewy bodies and loss of dopaminergic neurons in the substantia nigra pars compacta (SNc). Mitochondrial dysfunction is considered to be one of the most important causative mechanisms. In addition, dysfunction of chaperone-mediated autophagy (CMA), one of the lysosomal proteolytic pathways, has been shown to play an important role in the pathogenesis of PD. An exciting and important development is recent finding that CMA and mitochondrial quality control may be linked. This review summarizes the studies revealing the link between autophagy and mitochondrial function. Discussions are focused on the connections between CMA and mitochondrial failure and on the role of MEF2D, a neuronal survival factor, in mediating the regulation of mitochondria in the context of CMA. These new findings highlight the need to further explore the possibility of targeting the MEF2D-mitochondria-CMA network in both understanding the PD pathogenesis and developing novel therapeutic strategies.

• Publication year

  2016

• Venue

  Parkinson's Disease

• Publication date

  2016-06-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2016/2613401PMID 27413575PMCID 4927950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Oxidative stress and Parkinson's disease

  2017cited by this paper
• Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7

  2016cited by this paper
• Identification of a Novel Zn 2 !-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E 3 Ligase Parkin *

  2016cited by this paper
• Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease

  2016cited by this paper
• The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.

  2015influential reference
• Selective removal of mitochondria via mitophagy: distinct pathways for different mitochondrial stresses.

  2015cited by this paper
• Oxidative stress and Parkinson’s disease

  2015cited by this paper
• Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

  2015cited by this paper
• Mitochondria, autophagy and age-associated neurodegenerative diseases: New insights into a complex interplay.

  2015cited by this paper
• Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications

  2015cited by this paper
• Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA

  2015cited by this paper
• Chaperone-mediated autophagy: roles in neuroprotection

  2015cited by this paper
• Oxidation of Survival Factor MEF2D in Neuronal Death and Parkinson's Disease

  2014cited by this paper
• Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets?

  2014cited by this paper
• Phosphorylation‐Regulated Degradation of the Tumor‐Suppressor Form of PED by Chaperone‐Mediated Autophagy in Lung Cancer Cells

  2014cited by this paper
• Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation

  2014cited by this paper
• Genetics of Parkinson's disease: the yield.

  2014cited by this paper
• Mitochondrial Homeostasis Molecules: Regulation by a Trio of Recessive Parkinson's Disease Genes

  2014cited by this paper
• Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease

  2014cited by this paper
• Regulation by mitophagy.

  2014cited by this paper
• Mitochondrial quality control in neurodegenerative diseases.

  2014cited by this paper
• The role of protein clearance mechanisms in organismal ageing and age-related diseases

  2014cited by this paper
• The interplay between mitochondria and autophagy and its role in the aging process.

  2014cited by this paper
• Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control

  2014cited by this paper
• Chaperone-mediated autophagy: roles in disease and aging

  2013cited by this paper
• [Epidemiology of Parkinson's disease].

  2013cited by this paper
• The PINK1–Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo

  2013cited by this paper
• Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization

  2013cited by this paper
• Excitotoxicity: bridge to various triggers in neurodegenerative disorders.

  2013cited by this paper
• Mitophagy and Parkinson's disease: be eaten to stay healthy.

  2013cited by this paper
• Interplay of LRRK2 with chaperone-mediated autophagy

  2013cited by this paper
• Role of Oxidative Stress in Parkinson's Disease

  2013cited by this paper
• The Role of Oxidative Stress in Parkinson's Disease

  2013cited by this paper
• Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

  2013cited by this paper
• After the banquet

  2013cited by this paper
• Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival.

  2012cited by this paper
• Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

  2012cited by this paper
• Neuronal autophagy and neurodegenerative diseases

  2012cited by this paper
• The Parkinson's disease-related genes act in mitochondrial homeostasis.

  2012cited by this paper
• Chaperone-mediated autophagy: a unique way to enter the lysosome world.

  2012cited by this paper
• Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?

  2012cited by this paper
• Chaperone-mediated autophagy: machinery, regulation and biological consequences

  2011cited by this paper
• Autophagy for tissue homeostasis and neuroprotection.

  2011cited by this paper
• DJ-1 regulation of mitochondrial function and autophagy through oxidative stress

  2011cited by this paper
• Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients.

  2011influential reference
• Mechanisms of mitochondria and autophagy crosstalk

  2011cited by this paper
• PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin

  2010cited by this paper
• Dysregulation of autophagy and Parkinson’s disease: the MEF2D link

  2010cited by this paper
• PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1

  2010cited by this paper
• Chaperone-mediated autophagy markers in Parkinson disease brains.

  2010cited by this paper
• PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy

  2010cited by this paper
• Chaperone-mediated autophagy: selectivity pays off.

  2010cited by this paper
• The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations

  2010cited by this paper
• Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy

  2010cited by this paper
• IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome

  2009cited by this paper
• Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy

  2009cited by this paper
• PINK1-dependent recruitment of Parkin to mitochondria in mitophagy

  2009cited by this paper
• Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin*

  2009cited by this paper
• The Chaperone-Mediated Autophagy Receptor Organizes in Dynamic Protein Complexes at the Lysosomal Membrane

  2008cited by this paper
• Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

  2008cited by this paper
• Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

  2008cited by this paper
• Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells*

  2008cited by this paper
• Aberrant Interaction between Parkinson Disease-associated Mutant UCH-L1 and the Lysosomal Receptor for Chaperone-mediated Autophagy*

  2008cited by this paper
• Autophagy fights disease through cellular self-digestion

  2008cited by this paper
• Insights into links between familial and sporadic Parkinson's disease: Physical relationship between UCH-L1 variants and chaperone-mediated autophagy

  2008cited by this paper
• Chaperone-Mediated Autophagy

  2007cited by this paper
• DNA replication and transcription in mammalian mitochondria.

  2007cited by this paper
• Expression, Function, and Regulation of Transcription Factor MEF2 in Neurons

  2006cited by this paper
• Chaperone-mediated autophagy in aging and disease.

  2006cited by this paper
• Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

  2006cited by this paper
• Calpain-Regulated p35/cdk5 Plays a Central Role in Dopaminergic Neuron Death through Modulation of the Transcription Factor Myocyte Enhancer Factor 2

  2006cited by this paper
• Consequences of the selective blockage of chaperone-mediated autophagy.

  2006cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled

  2006cited by this paper
• The molecular machinery of autophagy: unanswered questions

  2005cited by this paper
• Cyclin-Dependent Kinase 5 Mediates Neurotoxin-Induced Degradation of the Transcription Factor Myocyte Enhancer Factor 2

  2005cited by this paper
• Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival

  2004cited by this paper
• Mechanisms of chaperone-mediated autophagy.

  2004cited by this paper
• Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

  2004cited by this paper
• Activation of chaperone-mediated autophagy during oxidative stress.

  2004cited by this paper
• Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

  2004cited by this paper
• Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

  2004cited by this paper
• Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease

  2003cited by this paper
• Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.

  2003cited by this paper
• Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

  2002cited by this paper
• Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor

  2002cited by this paper
• A molecular chaperone complex at the lysosomal membrane is required for protein translocation.

  2001cited by this paper
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

  2000cited by this paper
• Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state.

  2000cited by this paper
• Neuronal activity-dependent cell survival mediated by transcription factor MEF2.

  1999cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• The mtDNA‐encoded ND6 subunit of mitochondrial NADH dehydrogenase is essential for the assembly of the membrane arm and the respiratory function of the enzyme

  1998cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Parkinson's disease. Second of two parts.

  1998cited by this paper
• Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease

  1998cited by this paper
• A Receptor for the Selective Uptake and Degradation of Proteins by Lysosomes

  1996influential reference
• Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation.

  1995cited by this paper
• Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.

  1992cited by this paper

• OLFACTORY DYSFUNCTION: AN EARLY INDICATOR OF PARKINSON'S DISEASE

  2025cites this paper
• The zebrafish as a new model for studying chaperone-mediated autophagy unveils its role in spermatogenesis

  2024cites this paper
• Site‐specific photo‐crosslinking/cleavage for protein–protein interface identification reveals oligomeric assembly of lysosomal‐associated membrane protein type 2A in mammalian cells

  2023cites this paper
• Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson's Disease.

  2023cites this paper
• Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson's disease via promoting PLIN4 degradation

  2022cites this paper
• Chaperone-Mediated Autophagy: A Potential Target for Metabolic Diseases.

  2022cites this paper
• Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures

  2021cites this paper
• Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

  2019cites this paper
• Chaperone-mediated autophagy: Advances from bench to bedside.

  2019cites this paper
• Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities

  2019cites this paper
• Chaperone-mediated autophagy as a therapeutic target for Parkinson disease

  2018cites this paper
• Malfunctioning of Chaperone-Mediated Autophagy in Parkinson’s Disease: Feats, Constraints, and Flaws of Modulators

  2018cites this paper
• Mesencephalic astrocyte‐derived neurotrophic factor alleviated 6‐OHDA‐induced cell damage via ROS‐AMPK/mTOR mediated autophagic inhibition

  2017cites this paper
• A molecular window into Parkinson’s disease

  2017cites this paper
• Chaperone-mediated autophagy substrate proteins in cancer

  2017influential citation